Apogee Therapeutics shareholders elect directors and ratify auditor at 2025 annual meeting

Apogee Therapeutics, Inc.

Elected Class II directors: Bollinger (35.1M for, 4.3M withheld), Kiselak (39.2M for), Shah (25.8M for, 13.6M withheld).
Ratified Ernst & Young as independent auditor for FY2025 (41.2M for, 3K against).
Advisory vote on say-on-pay frequency: 39.4M voted for one year; company will hold annual say-on-pay votes going forward.
Broker non-votes of 1,795,017 on director elections and frequency vote.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.